SE421527B - Analogiforfarande for framstellninh av 1-(2'-aroyl-1'-etyl)-2-(4"-acetamido-1"-piperazinylmetyl)-bensimidazoler - Google Patents

Analogiforfarande for framstellninh av 1-(2'-aroyl-1'-etyl)-2-(4"-acetamido-1"-piperazinylmetyl)-bensimidazoler

Info

Publication number
SE421527B
SE421527B SE7600116A SE7600116A SE421527B SE 421527 B SE421527 B SE 421527B SE 7600116 A SE7600116 A SE 7600116A SE 7600116 A SE7600116 A SE 7600116A SE 421527 B SE421527 B SE 421527B
Authority
SE
Sweden
Prior art keywords
piperazinylmethyl
benzimidazoles
aroyl
acetamido
ethyl
Prior art date
Application number
SE7600116A
Other languages
English (en)
Swedish (sv)
Other versions
SE7600116L (sv
Inventor
C Fauran
M Turin
T Imbert
G Raynaud
N Dorme
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7500724A external-priority patent/FR2297045A1/fr
Priority claimed from FR7537297A external-priority patent/FR2333510A2/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of SE7600116L publication Critical patent/SE7600116L/xx
Publication of SE421527B publication Critical patent/SE421527B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7600116A 1975-01-10 1976-01-08 Analogiforfarande for framstellninh av 1-(2'-aroyl-1'-etyl)-2-(4"-acetamido-1"-piperazinylmetyl)-bensimidazoler SE421527B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7500724A FR2297045A1 (fr) 1975-01-10 1975-01-10 Nouveaux (aroyl-2' eth-1' yl)-1 (acetamido-4'' piperazin-1'' yl methyl)-2 benzimidazoles a proprietes antisecretoire gastrique et antiulcereuse
FR7537297A FR2333510A2 (fr) 1975-12-05 1975-12-05 Nouveaux (aroyl-2' eth-1 yl)-1 (acetamido-4'' piperazin-1'' yl methyl)-2 benzimidazoles, leur application en therapeutique et leur procede de preparation

Publications (2)

Publication Number Publication Date
SE7600116L SE7600116L (sv) 1976-07-12
SE421527B true SE421527B (sv) 1982-01-04

Family

ID=26218682

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7600116A SE421527B (sv) 1975-01-10 1976-01-08 Analogiforfarande for framstellninh av 1-(2'-aroyl-1'-etyl)-2-(4"-acetamido-1"-piperazinylmetyl)-bensimidazoler

Country Status (13)

Country Link
JP (1) JPS6020386B2 (OSRAM)
AU (1) AU509084B2 (OSRAM)
CA (1) CA1073455A (OSRAM)
CH (1) CH612675A5 (OSRAM)
DE (1) DE2557446C2 (OSRAM)
ES (1) ES444064A1 (OSRAM)
GB (1) GB1487128A (OSRAM)
IT (1) IT1062803B (OSRAM)
LU (1) LU74043A1 (OSRAM)
MX (1) MX3428E (OSRAM)
NL (1) NL7600224A (OSRAM)
SE (1) SE421527B (OSRAM)
SU (1) SU651701A3 (OSRAM)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2190439B1 (OSRAM) * 1972-07-06 1975-06-20 Delalande Sa

Also Published As

Publication number Publication date
LU74043A1 (OSRAM) 1976-11-11
JPS51131885A (en) 1976-11-16
AU1011776A (en) 1977-07-14
SU651701A3 (ru) 1979-03-05
CA1073455A (fr) 1980-03-11
DE2557446A1 (de) 1976-07-15
ES444064A1 (es) 1977-08-16
NL7600224A (nl) 1976-07-13
CH612675A5 (en) 1979-08-15
IT1062803B (it) 1985-02-11
DE2557446C2 (de) 1984-11-29
SE7600116L (sv) 1976-07-12
AU509084B2 (en) 1980-04-17
JPS6020386B2 (ja) 1985-05-21
MX3428E (es) 1980-11-21
GB1487128A (en) 1977-09-28

Similar Documents

Publication Publication Date Title
NO147025C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme pyridinyl-2(1h)-pyridinoner
SE438853B (sv) Forfarande for framstellning av 2-azetidinonforeningar
SE7603791L (sv) Forfarande for framstellning av 17 alfa-ester-21-halogenpregnaner
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
SE417610B (sv) Analogiforfarande for framstellning av 1-bensazolylalkyl-4-substituerade piperidiner
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
SE426490B (sv) Analogiforfarande for framstellning av 1-(bensazolylalkyl)piperidiner
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE435510B (sv) Analogiforfarande for framstellning av 3-fluor-6-piperazinylmorfantridiner
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
SE7613839L (sv) Forfarande for framstellning av 2(1h)-kinazolinonderivat
NO151196C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fluorerte alkenylendiaminderivater
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO152172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE421527B (sv) Analogiforfarande for framstellninh av 1-(2'-aroyl-1'-etyl)-2-(4"-acetamido-1"-piperazinylmetyl)-bensimidazoler
NO147103C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser
SE423233B (sv) Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
NO143314C (no) Fremgangsmaate for fremstilling av akrylamid
NO144214C (no) Analogifremgangsmaate for fremstilling av terapeutiak aktive fenyl-imidazoliner
NO145538C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-forbindelser
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat